10-120503895-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001030059.3(PLPP4):ā€‹c.134A>Gā€‹(p.Gln45Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

PLPP4
NM_001030059.3 missense

Scores

7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.65
Variant links:
Genes affected
PLPP4 (HGNC:23531): (phospholipid phosphatase 4) Enables diacylglycerol diphosphate phosphatase activity; identical protein binding activity; and phosphatidate phosphatase activity. Involved in phospholipid dephosphorylation and regulation of calcium ion import. Predicted to be located in plasma membrane. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32911974).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLPP4NM_001030059.3 linkuse as main transcriptc.134A>G p.Gln45Arg missense_variant 2/7 ENST00000398250.6 NP_001025230.1 Q5VZY2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLPP4ENST00000398250.6 linkuse as main transcriptc.134A>G p.Gln45Arg missense_variant 2/71 NM_001030059.3 ENSP00000381302.1 Q5VZY2-1
PLPP4ENST00000369073.3 linkuse as main transcriptn.104A>G non_coding_transcript_exon_variant 2/75

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000401
AC:
1
AN:
249352
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135270
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460770
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
726804
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.0000113
ExAC
AF:
0.00000828
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 21, 2024The c.134A>G (p.Q45R) alteration is located in exon 2 (coding exon 2) of the PLPP4 gene. This alteration results from a A to G substitution at nucleotide position 134, causing the glutamine (Q) at amino acid position 45 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.042
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.065
T;.;.
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.33
T;T;T
MetaSVM
Benign
-0.60
T
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-1.6
N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.22
T;T;T
Sift4G
Benign
0.44
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.49
MutPred
0.38
Gain of catalytic residue at Q45 (P = 0.1185);Gain of catalytic residue at Q45 (P = 0.1185);.;
MVP
0.79
MPC
0.39
ClinPred
0.51
D
GERP RS
5.3
Varity_R
0.19
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs779211632; hg19: chr10-122263407; API